Klin Farmakol Farm. 2024;38(1):15-21 | DOI: 10.36290/far.2024.007

Medication adherence - the way to understand patients

Patricia Schnorrerova1, Petra Matalova2, Martin Wawruch1
1 Institute of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
2 Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic

The aims of this review are to explore the critical issue of medication adherence, which is essential for effective healthcare outcomes but remains a significant challenge. The review delves into the diverse aspects of non-adherence, including patient perceptions, economic challenges, and complex treatment regimens. It emphasizes the importance of accurate adherence assessments, particularly through self-report questionnaires and retrospective database analyses. The review also explores the historical evolution of adherence concepts and highlights the critical role of pharmacists in educating patients and managing medication regimens. The importance of recognizing and addressing medication non-adherence as a significant health policy issue is underscored, advocating for improved measurement methods and interventions such as multidrug punch cards and medication charts. The review advocates for a patient-centered approach and multidisciplinary collaboration in healthcare, aiming to enhance healthcare outcomes and medication adherence through systemic changes. It also underscores the need for empowering pharmacists with expanded roles and appropriate tools within healthcare systems to further improve patient outcomes.

Keywords: medication adherence, adherence barriers, patient adherence, survey and questionnaires, self-report

Accepted: March 26, 2024; Published: April 8, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Schnorrerova P, Matalova P, Wawruch M. Medication adherence - the way to understand patients. Klin Farmakol Farm. 2024;38(1):15-21. doi: 10.36290/far.2024.007.
Download citation

References

  1. Jimmy B, Jose J. Patient Medication Adherence: Measures in Daily Practice. Oman Med J. 2011;26(3):155-159. Go to original source... Go to PubMed...
  2. Vervloet M, Linn AJ, van Weert JCM, et al. The effectiveness of interventions using electro­nic reminders to improve adherence to chronic medi­cation: A systematic review of the literature. Journal of the American Medical Informatics Asso­ciation. 2012;19(5):696-704. Go to original source... Go to PubMed...
  3. Baryakova TH, Pogostin BH, Langer R, et al. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nat Rev Drug Discov. 2023;22(5):387-409. Go to original source... Go to PubMed...
  4. Bosworth HB, Granger BB, Mendys P, et al. Medication adherence: A call for action. Am Heart J. 2011;162(3):412-424. Go to original source... Go to PubMed...
  5. Arbuckle C, Tomaszewski D, Brown L, et al. Exploring the relationship of digital information sources and medication adherence. Comput Biol Med. 2019;109:303-310. Go to original source... Go to PubMed...
  6. Partridge AH, Avorn J, Wang PS, et al. Adherence to Therapy With Oral Antineoplastic Agents, JNCI: Journal of the National Cancer Institute. 2002;94(9):652-661. Go to original source... Go to PubMed...
  7. Khan R, Socha-Dietrich K. Investing in medication adhe­rence improves health outcomes and health system efficiency: Adherence to medicines for diabetes, hypertension, and hyperlipidaemia. OECD Health Working Papers. 2018;(105).
  8. Cutler RL, Fernandez-Llimos F, Frommer M, et al. Economic impact of medication non-adherence by disease groups: A systematic review. BMJ Open. 2018;8(1). Go to original source... Go to PubMed...
  9. Valverde-Merino MI, Martinez-Martinez F, Garcia-Mochon L, et al. Cost-utility analysis of a medication adherence mana­gement service alongside a cluster randomized control trial in community pharmacy. Patient Prefer Adherence. 2021;15:2363-2376. Go to original source... Go to PubMed...
  10. Blaschke TF, Osterberg L, Vrijens B, et al. Adherence to medications: Insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol. 2012;52:275-301. Go to original source... Go to PubMed...
  11. Dietrich F, Polymeris AA, Albert V, et al. Intake reminders are effective in enhancing adherence to direct oral anticoagulants in stroke patients: a randomised cross-over trial (MAAESTRO study). J Neurol. 2023 Oct 13. Go to original source... Go to PubMed...
  12. Raparelli V PMCRLGLDBS. Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants. Thromb Haemost. 2017;117(2):209-218. Go to original source... Go to PubMed...
  13. Kim D, Yang PS, Jang E, et al. The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients. Europace. 2020;22(4):547-557. Go to original source... Go to PubMed...
  14. Solla-Ruiz I, Villanueva-Benito I, Paredes-Galán E, et al. Differences between patient-driven adherence to vitamin K anta­gonists and direct oral anticoagulants. Do few missed doses matter? ACO-MEMS Study. Thromb Res. 2019;179:20-27. Go to original source... Go to PubMed...
  15. Fetzer BC, Mupenda B, Lusiama J, et al. Barriers to and facilitators of adherence to pediatric antiretroviral therapy in a sub-Saharan setting: Insights from a quali­tative study. AIDS Patient Care STDS. 2011;25(10):611-621. Go to original source... Go to PubMed...
  16. Kvarnström K, Westerholm A, Airaksinen M, et al. Factors contributing to medication adherence in patients with a chronic condition: A scoping review of qualitative research. Pharmaceutics. 2021;13(7). Go to original source... Go to PubMed...
  17. Pushpangadan M, Feely M. Once a Day is Best: Evidence or Assumption? The Relationship Between Compliance and Dosage Frequency in Older People. Drugs Aging. 1998;13(3):223-227. Go to original source... Go to PubMed...
  18. Joyce GF. Understanding Primary Nonadherence. Am J Pharm Benefits. 2010;2(2):111-118.
  19. Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91. Go to original source... Go to PubMed...
  20. Demonceau J, Ruppar T, Kristanto P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: A systematic literature review and meta-analysis. Drugs. 2013;73(6):545-562. Go to original source... Go to PubMed...
  21. Gossec L, Tubach F, Dougados M, et al. Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature review. Am J Med Sci. 2007;334(4):248-254. Go to original source... Go to PubMed...
  22. Lehmann A, Aslani P, Ahmed R, et al. Assessing medication adherence: Options to consider. Int J Clin Pharm. 2014;36(1):55-69. Go to original source... Go to PubMed...
  23. Nadery Y, Khorasani P, Feizi A, et al. Causes of nonadherence to treatment in people with myocardial infarction: Content analysis. J Educ Health Promot. 2021;10(1). Go to original source... Go to PubMed...
  24. Wilhelmsen NC, Eriksson T. Medication adherence interventions and outcomes: An overview of systematic reviews. European Journal of Hospital Pharmacy. 2019;26(4):187-192. Go to original source... Go to PubMed...
  25. Mason M, Cho Y, Rayo J, et al. Technologies for Medication Adherence Monitoring and Technology Assessment Criteria: Narrative Review. JMIR Mhealth Uhealth. 2022;10(3). Go to original source... Go to PubMed...
  26. Park LG, Howie-Esquivel J, Dracup K. A quantitative systematic review of the efficacy of mobile phone interventions to improve medication adherence. J Adv Nurs. 2014;70(9):1932-1953. Go to original source... Go to PubMed...
  27. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074-1090. Go to original source... Go to PubMed...
  28. Basu S, Garg S, Sharma N, et al. Improving the assessment of medication adherence: Challenges and considerations with a focus on low-resource settings. Tzu Chi Med J. 2019;31(2):73-80. Go to original source... Go to PubMed...
  29. Giardini A, Martin MT, Cahir C, et al. Toward appropriate criteria in medication adherence assessment in older persons: Position Paper. Aging Clin Exp Res. 2016;28(3):371-381. Go to original source... Go to PubMed...
  30. Dima AL, Dediu D. Computation of adherence to medication and visualization of medication histories in R with AdhereR: Towards transparent and reproducible use of electronic healthcare data. PLoS One. 2017;12(4). Go to original source... Go to PubMed...
  31. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: Its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028-3035. Go to original source... Go to PubMed...
  32. Kronish IM, Thorpe CT, Voils CI. Measuring the multi­ple domains of medication nonadherence: Findings from a Delphi survey of adherence experts. Transl Behav Med. 2021;11(1):104-113. Go to original source... Go to PubMed...
  33. Ilardo ML, Speciale A. The community pharmacist: Perceived barriers and patient-centered care communication. Int J Environ Res Public Health. 2020;17(2). Go to original source... Go to PubMed...
  34. Dalton K, Byrne S. Role of the pharmacist in reducing healthcare costs: current insights. Integr Pharm Res Pract. 2017;6:37-46. Go to original source... Go to PubMed...
  35. McLean G, Band R, Saunderson K, et al. Digital interventions to promote self-management in adults with hypertension systematic review and meta-analysis. J Hypertens. 2016;34(4):600-612. Go to original source... Go to PubMed...
  36. Meddings J, Kerr EA, Heisler M, et al. Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: Still no better than a coin toss. BMC Health Serv Res. 2012;12(1). Go to original source... Go to PubMed...
  37. Weir MR, Maibach EW, Bakris GL, et al. Implications of a health lifestyle and medication analysis for improving hypertension control. Arch Intern Med. 2000;160(4):481-490. Go to original source... Go to PubMed...
  38. Dietrich F, Zeller A, Haag M, et al. Communicating electronic adherence data to physicians - consensus-based development of a compact reporting form. Int J Environ Res Public Health. 2021;18(19). Go to original source... Go to PubMed...
  39. Lerner BH. From careless consumptives to recalcitrant patients: the historical construction of noncompliance. Soc Sci Med. 1997;45(9):1423-1431. Go to original source... Go to PubMed...
  40. Rafii F, Fatemi NS, Danielson E, et al. Compliance to treatment in patients with chronic illness: A concept exploration. Iran J Nurs Midwifery Res. 2014;19(2):159-167.
  41. Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691-705. Go to original source... Go to PubMed...
  42. Sabaté E. World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization; 2003.
  43. De Geest S, Zullig LL, Dunbar-Jacob J, et al. ESPACOMP medication adherence reporting guideline (EMERGE). Ann Intern Med. 2018;169(1):30-35. Go to original source... Go to PubMed...
  44. Martin LR, Williams SL, Haskard KB, et al. The challenge of patient adherence. Ther Clin Risk Manag. 2005;1(3):189-199.
  45. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304-314. Go to original source... Go to PubMed...
  46. Arnet I, Haefeli WE. Compliance: Fakten Perspektiven. Managed Care. 1998;3:27-31.
  47. Penna R, Knowlton C. The need for pharmaceutical care. In: Pharmaceutical Care. Taylor & Francis; 1998:225-226.
  48. Fallsberg M. Reflection on Medicines and Medication - a Qualitative Analysis among People on Long-Term Drug Regimens. Linkoping University; 1991.
  49. Rimer B, & GB. How Do Persuasive Health Messages Work? A Health Education Field Study. Health Educ Q. 1984;11(3): 313-321. Go to original source... Go to PubMed...
  50. Hatoum HT, HRA, & LBL. OBRA 90: Patient counseling-enhancing patient outcomes. US pharmacist. 1993;18(1):75-86.
  51. Boeni F, Hersberger KE, Arnet I. Multidrug punch cards in primary care: A mixed methods study on patients' preferences and impact on adherence. Front Pharmacol. 2014;5(SEP). Go to original source... Go to PubMed...
  52. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting. JAMA. 2003;289(9):1107-1116. Go to original source... Go to PubMed...
  53. Vermeire E, Hearnshaw H, Van Royen P, et al. Patient adherence to treatment: Three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26(5):331-342. Go to original source... Go to PubMed...
  54. Col N FJKP. The Role of Medication Noncompliance and Adverse Drug Reactions in Hospitalizations of the Elderly. Arch Intern Med. 1990;150(4):841-845. Go to original source...
  55. Bae SG, Kam S, Park KS, et al. Factors related to intentional and unintentional medication nonadherence in elderly patients with hypertension in rural community. Patient Prefer Adherence. 2016;10:1979-1989. Go to original source... Go to PubMed...
  56. Dalli LL, Kilkenny MF, Arnet I, et al. Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN-SPIDERS. Br J Clin Pharmacol. 2022;88(10):4427-4442. Go to original source... Go to PubMed...
  57. Wawruch M, Wimmer G, Murin J, et al. Non-adherence to statin treatment in older patients with peripheral arterial disease depending on persistence status. Biomedicines. 2020;8(10):1-12. Go to original source... Go to PubMed...
  58. Wawruch M, Petrova M, Tesar T, et al. Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral arterial disease. Front Pharmacol. 2023;14. Go to original source... Go to PubMed...
  59. Kozma C, Dickson, Phillips, Meletiche. Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis. Patient Prefer Adherence. [Internet] 2013;509 [cited 2023 Dec 10]. Go to original source... Go to PubMed...
  60. Bruthans J, Berger J, Šoltés J, et al. Using the natio­nal electronic prescription system to determine the primary non-adherence to medication in the Czech Republic. Front Pharmacol. 2023;14. Go to original source... Go to PubMed...
  61. Bauer AM, Schillinger D, Parker MM, et al. Health literacy and antidepressant medication adherence among adults with diabetes: The diabetes study of Northern California (DISTANCE). J Gen Intern Med. 2013;28(9):1181-1187. Go to original source... Go to PubMed...
  62. Fernández A, Quan J, Moffet H, et al. Adherence to newly prescribed diabetes medications among insured Latino and white patients with diabetes. JAMA Intern Med. 2017;177(3):371-379. Go to original source... Go to PubMed...
  63. Williams JLS, Walker RJ, Smalls BL, et al. Effective interventions to improve medication adherence in Type 2 diabetes: a systematic review. Diabetes Management. 2014;4(1):29-48. Go to original source... Go to PubMed...
  64. Arnet I, Sahm LJ, Gregório J, et al. Development and validation of the 15-STARS - A novel self-report pharmacy-based questionnaire to screen for medication non-adherence. Res Social Adm Pharm. 2023:S1551-7411(23)00487-4.
  65. Mokkink LB, Prinsen C, Patrick D, et al. COSMIN methodology for systematic reviews of Patient-Reported Outcome Measures (PROMs) - user manual. [Internet] 2018. [cited 2023 Dec 10]Available at: https://cosminnl/wp-content/uploads/COSMIN-syst-review-for-PROMs-manual_version-1_feb-2018pdf.
  66. Arnet I, Caloz S, Eickhoff C, et al. Psychometric Quality of Questionnaires on Medication Adherence - a Secondary Analysis. Live paper presentation at the 27th Annual Conference of ESPACOMP. Budapest, 2. 12. 2023.
  67. Gregoriano C, Dieterle T, Breitenstein AL, et al. Does a tailored intervention to promote adherence in patients with chronic lung disease affect exacerbations? A randomized controlled trial. Respir Res. 2019;20(1). Go to original source... Go to PubMed...
  68. Torres-Robles A, Wiecek E, Tonin FS, et al. Comparison of interventions to improve long-term medication adherence across different clinical conditions: A systematic review with network meta-analysis. Front Pharmacol. 2018;9. Go to original source... Go to PubMed...
  69. Mills EJ, Lester R, Thorlund K, et al. Interventions to promote adherence to antiretroviral therapy in Africa: A network meta-analysis. Lancet HIV. 2014;1(3):104-111. Go to original source... Go to PubMed...
  70. Van Driel ML, Morledge MD, Ulep R, et al. Interventions to improve adherence to lipid-lo­wering medication. Cochrane Database of Systematic Reviews. 2016;2016(12). Go to original source... Go to PubMed...
  71. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medica­tion nonadhe­rence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836-1841. Go to original source... Go to PubMed...
  72. Dietrich FM, Hersberger KE, Arnet I. Benefits of medication charts provided at transitions of care: A narrative systematic review. BMJ Open. 2020;10(10). Go to original source... Go to PubMed...
  73. Marquis J, Schneider MP, Payot V, et al. Swallowing difficulties with oral drugs among polypharmacy patients attending community pharmacies. Int J Clin Pharm. 2013;35(6):1130-1136. Go to original source... Go to PubMed...
  74. Berkhout C, Berbra O, Favre J, et al. Defining and evalua­ting the Hawthorne effect in primary care, a systematic review and meta-analysis. Front Med (Lausanne). 2022;9. Go to original source... Go to PubMed...
  75. Haskard Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: A meta-analysis. Med Care. 2009;47(8):826-834. Go to original source... Go to PubMed...
  76. Hepler CD, SLM. Opportunities and responsibilities in pharmaceutical care. Am J Pharm Ed. 1990;53:75-155. Go to original source...
  77. Boeni F, Arnet I, Hersberger KE. Adherence counseling during patient contacts in Swiss community pharmacies. Patient Prefer Adherence. 2015;9:597-605. Go to original source... Go to PubMed...
  78. Cipolle RJ, SLM and MPC. Pharmaceutical Care Practice. Health Professions Division; 1998.




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.